| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | €136.6M | +0.3% |
| Gross Profit | €41.4M | +1.3% |
| EBITDA | — | — |
| Net Income | -€22.9M | — |
| Diluted EPS | €0.00 | — |
| Free Cash Flow | €9.0M | +118.3% |
| Ratio | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 5y | vs own |
|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||
| Gross Margin | — | 29.79% | 34.05% | 30.02% | 30.32% | 63% | |
| Operating Margin | — | 3.58% | −44.54% | −6.79% | −3.21% | 63% | |
| NOPAT Margin | — | 1.46% | −35.19% | −5.36% | −2.53% | 63% | |
| Net Margin | — | 0.58% | −43.12% | −13.12% | −16.72% | 38% | |
| FCF Margin | — | −35.04% | −8.05% | 3.02% | 6.56% | 88% | |
| FCFF Margin | — | −34.25% | — | — | — | — | — |
| FCFE Margin | — | 10.06% | −1.88% | −2.20% | 6.56% | 63% | |
| OCF Margin | — | 1.88% | 10.33% | 5.29% | 7.85% | 63% | |
| Capex Intensity | — | 36.91% | 18.38% | 2.27% | 1.28% | 13% | |
| ▸Returns on Capital · 3 ratios | |||||||
| ▸DuPont factors (ROE drivers) · 2 ratios | |||||||
| ▸Earnings quality · 4 ratios | |||||||
| ▸Liquidity & coverage · 7 ratios | |||||||
| ▸Leverage · 5 ratios | |||||||
| ▸Working capital · 8 ratios | |||||||
| ▸Capital allocation · 1 ratios | |||||||
| Line | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | €120.9M | €162.0M | €136.2M | €136.6M |
| YoY % | +34.1% | -16.0% | +0.3% | ||
| Cost of Revenue | — | €84.9M | €106.9M | €95.3M | €95.2M |
| YoY % | +25.9% | -10.8% | -0.1% | ||
| Gross Profit | — | €36.0M | €55.2M | €40.9M | €41.4M |
| YoY % | +53.2% | -25.9% | +1.3% | ||
| Operating Income | — | €4.3M | -€72.2M | -€9.2M | -€4.4M |
| Interest Expense | — | €2.3M | -€6.1M | €3.9M | €4.9M |
| YoY % | +24.9% | ||||
| Interest & Investment Income | — | €0 | €0 | €138,000 | €304,000 |
| YoY % | +120.3% | ||||
| Equity Method Income | — | -€261,000 | -€1.0M | -€4.1M | -€11.9M |
| Pretax Income | — | €1.7M | -€67.1M | -€17.1M | -€20.8M |
| Income Tax | — | €1.0M | €2.8M | €765,000 | €2.0M |
| YoY % | +174.6% | -72.6% | +167.2% | ||
| Net Income (incl. NCI) | -€911,000 | €698,000 | -€69.9M | -€17.9M | -€22.9M |
| EPS (Basic) | — | €0.01 | -€0.19 | -€0.08 | -€0.10 |
| EPS (Diluted) | — | €0.01 | €0.00 | €0.00 | €0.00 |
| YoY % | -100.0% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
